Man Group
TWST icon

Man Group’s Twist Bioscience TWST Stock Holding History

Man Group’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6M Sell
58,295
-38,175
-40% -$2.48M 0.01% 1037
2026
Q1 		$4.58M Buy
+96,470
New +$4.33M 0.01% 1205
2025
Q4 		– Sell
-76,124
Closed -$2.14M – 2478
2025
Q3 		$2.14M Sell
76,124
-30,385
-29% -$920K ﹤0.01% 1396
2025
Q2 		$3.92M Buy
106,509
+5,348
+5% +$185K 0.01% 1156
2025
Q1 		$3.97M Sell
101,161
-860
-0.8% -$38.7K 0.01% 1109
2024
Q4 		$4.74M Sell
102,021
-27,588
-21% -$1.25M 0.01% 1035
2024
Q3 		$5.86M Sell
129,609
-63,479
-33% -$3.02M 0.02% 968
2024
Q2 		$9.52M Sell
193,088
-35,363
-15% -$1.44M 0.02% 723
2024
Q1 		$7.84M Sell
228,451
-61,793
-21% -$2.23M 0.02% 803
2023
Q4 		$10.7M Buy
+290,244
New +$6.71M 0.03% 613
2023
Q3 		– Sell
-428,057
Closed -$9.41M – 668
2023
Q2 		$8.76M Buy
+428,057
New +$6.41M 0.03% 664
2023
Q1 		– Sell
-62,103
Closed -$1.37M – 1052
2022
Q4 		$1.48M Buy
+62,103
New +$1.8M 0.01% 1206
2022
Q2 		– Sell
-9,226
Closed -$455K – 2411
2022
Q1 		$455K Buy
9,226
+59
+0.6% +$3.27K ﹤0.01% 1608
2021
Q4 		$710K Buy
9,167
+1,364
+17% +$140K ﹤0.01% 1428
2021
Q3 		$834K Buy
7,803
+4,700
+151% +$538K ﹤0.01% 1385
2021
Q2 		$413K Sell
3,103
-806
-21% -$93.7K ﹤0.01% 1616
2021
Q1 		$484K Sell
3,909
-23,054
-86% -$3.5M ﹤0.01% 1488
2020
Q4 		$3.81M Buy
26,963
+7,800
+41% +$865K 0.02% 945
2020
Q3 		$1.46M Buy
+19,163
New +$1.19M 0.01% 1288
2020
Q1 		– Sell
-12,000
Closed -$252K – 1895
2019
Q4 		$252K Sell
12,000
-3,000
-20% -$70.2K ﹤0.01% 1708
2019
Q3 		$358K Buy
+15,000
New +$436K ﹤0.01% 1634

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Man Group's TWST Position: Q2 2026 in Review

Man Group reduced its Twist Bioscience (TWST) stake by 40% in Q2 2026, selling an estimated $2.48M and leaving 58,295 shares worth $6M. The position accounts for 0.01% of the portfolio, ranked #1037.

Man Group first reported a position in TWST in Q3 2019 and has held it in 21 quarters since. The position peaked at $10.7M in Q4 2023. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Man Group held 58,295 shares of Twist Bioscience worth $6M as of Q2 2026.
  • Man Group sold 38,175 Twist Bioscience shares in Q2 2026, an estimated $2.48M.
  • Twist Bioscience made up 0.01% of Man Group's portfolio in Q2 2026, its #1037 holding.
  • Man Group first reported a position in Twist Bioscience in Q3 2019 and has held it in 21 quarters since.
  • Man Group's Twist Bioscience position peaked at $10.7M in Q4 2023.
  • 338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.